Astrazeneca Pharma India Ltd Financial Statement - Astrazeneca Pharma India Ltd Balance Sheet | Research 360 by Motilal Oswal
15:46 Apr 19

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5189.70
-34.45 (-0.66%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

AstraZeneca Pharma India Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5189.70
-34.45 (-0.66%)
15:46 Apr 19
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

9/100
Expensive Valuation

Technical

52/100
Technically Neutral

Strength

5

Weakness

3

Opportunity

0

Threats

2

16.86 %

ROE %

10.08 %

ROA %

39.70

EPS

235.48

BVPS

0.00 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM 2023
Net Sales
831.81 813.56 805.6 1002.97 1197.03
Operating Expenses +
711.11 678.09 719.42 837.85 1002.11
Raw Material
344.44 292 297.49 408.84 645.05
Increase Decrease in Cost
-39.21 2.95 14.47 -48.86 -165.42
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
216.7 219.54 230.21 259.1 250.33
Miscellaneous Expenses
737.64 553.08 593.01 867.69 272.15
Operating Profit
120.7 135.47 86.18 165.12 194.92
Other Income
12.99 12.84 14.76 26.1 34.13
Depreciation
18.58 20.13 16.95 16.26 15.42
Interest
1.14 1.09 0.95 0.63 1.35
Profit before tax and exceptio..
113.97 127.09 83.04 174.33 212.28
Exceptional Items
0 0 0 -40.23 -23.8
PBT
113.97 127.09 83.04 134.1 236.08
Provision for Taxation
41.76 33.79 21.44 34.81 49.16
Net Profit
72.21 93.3 61.6 99.29 139.3
NET Profit after MI
0 0 0 0 0
EPS
28.9 37.3 24.6 39.7 55.72
Operating Profit Margin (%)
14.51 16.65 10.7 16.46 16.28
Net Profit Margin (%)
8.68 11.47 7.65 9.9 11.64

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 75.00 75.00 75.00 75.00 75.00
FII 2.70 2.70 2.70 2.70 2.70
MF 3.80 2.80 2.40 1.80 1.20
Public 18.50 19.60 19.90 20.40 20.90
Others 0.00 -0.10 0.00 0.10 0.20
Shareholder Shares Holding %

Download Our App On: